Products

All products

Consumables

Services
MinION GridION PromethION 2 & 2 Solo PromethION 24 & 48 Flongle VolTRAX Q-Line

Consumables

Flow cells Manual & automated library prep

Services

Certification Training Device warranty
Applications

Nanopore sequencing offers advantages in all areas of research. Our offering includes DNA sequencing, as well as RNA and gene expression analysis and future technology for analysing proteins.

Learn about applications

Research areas

Investigations

Techniques

Research areas

Microbiology Human genetics Microbiome Clinical research Cancer Plant Transcriptome Animal Population genomics COVID-19 Environmental research & conservation Infectious disease

Investigations

Structural variation SNVs and phasing Gene expression Identification Splice variation Assembly Fusion transcripts Epigenetics Single cell Chromatin conformation

Techniques

Whole genome Targeted Whole transcriptome Metagenomics Short fragment mode View all Applications
Store Resources Support

Support & documentation

Learning

Support & documentation

Getting started FAQs Nanopore community Documentation Software downloads Library prep protocols Extraction protocols

Learning

Nanopore Learning How nanopore technology works Sample preparation Basecalling & analysis
About

Company

News & Events

Global partners

About

About us Board members Executive team Investor centre Company history Sustainability Careers Media resources

News & Events

News Events Blogs

Global partners

Global distributors Japanese dealers Sequencing service providers For partners

London Calling 2023

17th - 19th May
Find out more
Get started Talk to us Subscribe
Support
HomeAbout usInvestor centre

Reports & presentations

28 September 2022

Bernstein 19th Annual Pan European Strategic Decisions Conference

Gordon Sanghera CEO, will participate in an analyst led fireside chat at 11am BST/ 6am EST
15 September 2022

BofA Global Healthcare Conference 2022

Gordon Sanghera CEO, will participate in an analyst led fireside chat at 4:45pm BST/11:45am EST
13 September 2022

Interim Results for the six months ended 30 June 2022
22 March 2022

Annual Results for the year ended 31 December 2021
11 January 2022

J.P. Morgan Virtual Healthcare Conference